Goldman Sachs’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.9M Buy
775,753
+173,088
+29% +$8.45M 0.01% 1310
2025
Q1
$30.7M Sell
602,665
-161,960
-21% -$8.25M 0.01% 1394
2024
Q4
$34.5M Sell
764,625
-57,816
-7% -$2.61M 0.01% 1342
2024
Q3
$30.5M Buy
822,441
+31,277
+4% +$1.16M ﹤0.01% 1415
2024
Q2
$24.2M Buy
791,164
+311,143
+65% +$9.51M ﹤0.01% 1458
2024
Q1
$14M Sell
480,021
-46,473
-9% -$1.35M ﹤0.01% 1798
2023
Q4
$14.5M Buy
526,494
+186,608
+55% +$5.14M ﹤0.01% 1804
2023
Q3
$7.62M Sell
339,886
-86,346
-20% -$1.94M ﹤0.01% 2176
2023
Q2
$17.3M Sell
426,232
-26,450
-6% -$1.08M ﹤0.01% 1653
2023
Q1
$21.9M Sell
452,682
-80,352
-15% -$3.89M 0.01% 1465
2022
Q4
$20.3M Buy
533,034
+27,556
+5% +$1.05M 0.01% 1606
2022
Q3
$25.4M Buy
505,478
+9,298
+2% +$467K 0.01% 1423
2022
Q2
$19.9M Buy
496,180
+267,773
+117% +$10.7M 0.01% 1616
2022
Q1
$8.52M Sell
228,407
-298,926
-57% -$11.2M ﹤0.01% 2365
2021
Q4
$21M Buy
527,333
+299,114
+131% +$11.9M ﹤0.01% 1718
2021
Q3
$8.49M Sell
228,219
-41,095
-15% -$1.53M ﹤0.01% 2394
2021
Q2
$11.4M Sell
269,314
-244,789
-48% -$10.3M ﹤0.01% 2158
2021
Q1
$24.3M Sell
514,103
-192,787
-27% -$9.13M 0.01% 1544
2020
Q4
$43.1M Buy
706,890
+321,859
+84% +$19.6M 0.01% 1056
2020
Q3
$18M Sell
385,031
-475,814
-55% -$22.2M 0.01% 1550
2020
Q2
$43.7M Buy
860,845
+259,100
+43% +$13.1M 0.01% 943
2020
Q1
$26.8M Buy
601,745
+105,510
+21% +$4.71M 0.01% 1158
2019
Q4
$23.8M Buy
496,235
+81,650
+20% +$3.92M 0.01% 1504
2019
Q3
$14M Sell
414,585
-20,507
-5% -$694K ﹤0.01% 1765
2019
Q2
$19.6M Sell
435,092
-178,935
-29% -$8.05M 0.01% 1594
2019
Q1
$23.1M Buy
614,027
+83,113
+16% +$3.13M 0.01% 1518
2018
Q4
$18.2M Sell
530,914
-270,729
-34% -$9.29M 0.01% 1573
2018
Q3
$37.7M Sell
801,643
-185,860
-19% -$8.74M 0.01% 1259
2018
Q2
$33.3M Buy
987,503
+566,208
+134% +$19.1M 0.01% 1342
2018
Q1
$11.4M Sell
421,295
-375,223
-47% -$10.2M ﹤0.01% 1843
2017
Q4
$13.3M Buy
796,518
+514,068
+182% +$8.57M ﹤0.01% 1762
2017
Q3
$5.65M Buy
282,450
+54,973
+24% +$1.1M ﹤0.01% 2279
2017
Q2
$4.17M Sell
227,477
-71,358
-24% -$1.31M ﹤0.01% 2374
2017
Q1
$2.94M Buy
298,835
+217,192
+266% +$2.14M ﹤0.01% 2499
2016
Q4
$891K Sell
81,643
-67,956
-45% -$742K ﹤0.01% 3149
2016
Q3
$2.1M Buy
149,599
+80,576
+117% +$1.13M ﹤0.01% 2687
2016
Q2
$485K Buy
69,023
+56,265
+441% +$395K ﹤0.01% 3335
2016
Q1
$82K Sell
12,758
-218,285
-94% -$1.4M ﹤0.01% 4090
2015
Q4
$7.49M Buy
231,043
+160,230
+226% +$5.19M ﹤0.01% 1829
2015
Q3
$1.89M Buy
70,813
+20,840
+42% +$556K ﹤0.01% 2576
2015
Q2
$2.41M Buy
49,973
+16,097
+48% +$775K ﹤0.01% 2471
2015
Q1
$2.06M Buy
33,876
+14,293
+73% +$870K ﹤0.01% 2522
2014
Q4
$1.01M Sell
19,583
-12,874
-40% -$667K ﹤0.01% 2916
2014
Q3
$1.43M Buy
+32,457
New +$1.43M ﹤0.01% 2695
2014
Q1
Sell
-17,407
Closed -$295K 4380
2013
Q4
$295K Sell
17,407
-9,869
-36% -$167K ﹤0.01% 3704
2013
Q3
$585K Buy
+27,276
New +$585K ﹤0.01% 3245